Paralytic ileus possibly associated with interaction between ritonavir/lopinavir and vincristine

Pharmacy World and Science

Volumn 31, Issue 6, 2009, Pages 619-621

  Levêque, Dominique ^a   Santucci, Raoul ^a   Pavillet, Julien ^a   Herbrecht, Raoul ^a   Bergerat, Jean Pierre ^a  

^a HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

Drug drug interaction; Paralytic ileus; Ritonavir lopinavir; Vincristine

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; CYTOCHROME P450 3A5; DOXORUBICIN; ETOPOSIDE; GLYCOPROTEIN P; IFOSFAMIDE; ISOENZYME; LOPINAVIR PLUS RITONAVIR; METHOTREXATE; VINCRISTINE;

ABDOMINAL PAIN; ADULT; ARTICLE; BURKITT LYMPHOMA; CASE REPORT; CONSTIPATION; DISEASE SEVERITY; DRUG ELIMINATION; DRUG METABOLISM; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG TRANSPORT; FRANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MULTIPLE CYCLE TREATMENT; PARALYTIC ILEUS;

ABDOMINAL PAIN; ADULT; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BURKITT LYMPHOMA; CONSTIPATION; DRUG INTERACTIONS; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; INTESTINAL PSEUDO-OBSTRUCTION; MALE; PYRIMIDINONES; RITONAVIR; VINCRISTINE;

EID: 76749149610     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-009-9323-y     Document Type: Article

References (10)

1. D Levêque F Jehl 2007 Molecular pharmacokinetics of catharanthus (vinca) alkaloids J Clin Pharmacol 47 579 588 10.1177/0091270007299430 17442684 (Pubitemid 46632154)
2. PJ Toghill JD Burke 1970 Death from paralytic ileus following vincristine therapy Postgrad Med J 46 330 331 10.1136/pgmj.46.535.330 1:STN:280: DyaE3c3ls1Kgsg%3D%3D 5270680
3. M Bermudez JL Fuster E Llinares A Galera C Gonzales 2005 Itraconazole-related increased vincristine neurotoxicity J Pediatr Hematol Oncol 27 389 392 10.1097/01.mph.0000172751.06286.5b 16012330 (Pubitemid 41077029)
4. S Harnicar N Adel J Jurcic 2005 Modification of vincristine dosing during concomitant azole therapy in adult acute lymphoblastic leukemia patients J Oncol Pharm Pract 15 175 182 10.1177/1078155208101959
5. JB Dennison P Kulanthaivel RJ Barbuch JL Renbarger WJ Ehlhardt SD Hall 2006 Selective metabolism of vincristine in vitro by CYP3A5 Drug Metab Dispos 34 1317 1327 10.1124/dmd.106.009902 1:CAS:528:DC%2BD28Xnslakur0%3D 16679390 (Pubitemid 44079872)
6. JB Dennison MA Mohutsky RJ Barbuch SA Wrighton SD Hall 2008 Apparent high CYP3A5 expression is required for significant metabolism of vincristine by human cryopreserved hepatocytes J Pharmacol Exp Ther 327 248 257 10.1124/jpet.108.139998 1:CAS:528:DC%2BD1cXht1amsLfJ 18650247
7. S Quaranta D Chevalier D Allorge JM Lo-Guidice F Migot-Nabias A Kenani M Imbenotte F Broly B Lacarelle M Lhermitte 2006 Ethnic differences in the distribution of CYP3A5 gene polymorphisms Xenobiotica 36 1191 1200 10.1080/00498250600944300 1:CAS:528:DC%2BD2sXhs1Kkuw%3D%3D 17162466 (Pubitemid 44949961)
8. CS Ernest SD Hall DR Jones 2005 Mechanism-based inactivation of CYP3A by HIV protease inhibitors J Pharmacol Exp Ther 312 83 91
9. CH Storch D Theile H Lindenmaier WE Haefeli J Weiss 2007 Comparison of the inhibitory activity of anti-HIV drugs on P-glycoprotein Biochem Pharmacol 73 1573 1581 10.1016/j.bcp.2007.01.027 1:CAS:528:DC%2BD2sXjvFOmtb4%3D 17328866 (Pubitemid 46527547)
10. E Vaccher M Spina G di Gennaro R Talamini G Nasti O Schioppa G Vultaggio U Tirelli 2001 Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non Hodgkin lymphoma Cancer 91 155 163 10.1002/1097-0142(20010101)91:1<155::AID-CNCR20>3.0.CO;2-B 1:CAS:528:DC%2BD3MXot1GksQ%3D%3D 11148572 (Pubitemid 32052626)